CYP27A1 and neoplasm: The mean survival in patients with tumours showing moderate/strong staining for CYP27A1 (n=60) was 82 months (95% CI 65-98) whereas for negative/weak tumours (n=562) the mean survival was 119 months (95% CI 110-127).